Evidence map›Paper›PMID 41688519›Full record

ArticleScientific reports2026

Time to death and its predictors among adults living with HIV receiving ART in Ethiopia applying proportional hazard model.

Muhammed Hussen, Amare Muche, Elsabeth Addisu, Gudina Egata

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Muhammed HussenDepartment of Epidemiology and Biostatistics, School of Public Health, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
Amare MucheDepartment of Epidemiology and Biostatistics, School of Public Health, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
Elsabeth AddisuDepartment of Reproductive Health, School of Public Health, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia. elsabethko@gmail.com.
Gudina EgataSchool of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, more than 32.7 million AIDS-related deaths have occurred, and about 38 million people were living with HIV by the end of 2019, yet only half had access to ART. Despite Ethiopia's long-standing ART program, evidence on mortality and its predictors remains limited in the study area, creating an information gap for policymakers. This study aimed to assess time to death and its predictors among adults living with HIV on ART at public health facilities, Northeast Ethiopia. A retrospective follow-up study was used among 602 study participants selected by simple random sampling method from clients enrolled for ART from July 8, 2010 to July 7, 2020 in public health facilities of Kemise town. Descriptive statistics was used to describe cohort characteristics and Kaplan-Meier analysis to estimate survival probability. Bi-variable and multivariable Cox-regression analysis was used to identify predictors of mortality. Hazard ratios along with 95% confidence interval (CI) were estimated to measure the strength of the association. Level of statistical significance was declared at p-value ≤ 0.05. Among 602 ART naïve study cohort, 108 patients were died with cumulative incidence density of 4.14 (95% CI (3.43, 5.00) per 100 Person Year Observed (PYO). The predictors of mortality were rural residents [adjusted hazard ratio (AHR) = 1.51, 95% CI (1.01, 2.28)], not taking co-trimoxazole prophylactic therapy(CPT) [AHR = 4.52, 95% CI (2.83, 7.21)], having co-morbidities [AHR = 1.64, 95% CI (1.06-2.55)], Patients with opportunistic infections (OIs) [AHR = 4.45, 95% CI (2.07, 9.59)], bedridden functional status [AHR = 3.21, 95% CI (1.52, 6.77)], unsuppressed viral load [AHR = 2.45, 95% CI (1.17, 5.10)], TB co-infection[AHR = 3.91, 95% CI (1.89, 8.08)], baseline CD

Indexed as

Anti-HIV AgentsHIV InfectionsAdultAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountEthiopiaFemaleFollow-Up StudiesHumansMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesYoung AdultAnti-HIV AgentsAdultEthiopiaHAARTHIV/AIDSPredictorsTime to death

Identifiers

PMID41688519
PMCPMC12982795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.